A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT01130142 · COMPLETED
Trial details
- NCT number
- NCT01130142
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-05-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.